Arthritis: Symptoms, Types, Causes & Integrative Treatment NYC

Arthritis

Arthritis: Symptoms, Types, Causes & Integrative Treatment in NYC

Arthritis is a chronic inflammatory joint condition affecting more than 58 million Americans — driven not just by wear and tear, but by systemic inflammation, gut dysbiosis, hormonal imbalance, and metabolic dysfunction. For many patients, the pain, stiffness, and fatigue of arthritis are signals from a body whose root-cause drivers have never been fully addressed.

58.5M

Americans living with arthritis

100+

Distinct types of arthritis

60%

Of cases occur in women

#1

Cause of work disability in the US

Medically reviewed by Dr. Rashmi Gulati, MD — Medical Director, Patients Medical.

Board-certified integrative medicine physician.

Clinical Definition

Arthritis is a broad medical term encompassing more than 100 types of joint disease characterised by inflammation of one or more joints, progressive degradation of articular cartilage, synovial membrane hyperplasia, and varying degrees of periarticular structural damage. The most prevalent forms — osteoarthritis and rheumatoid arthritis — arise through distinct but often overlapping pathways involving mechanical wear, immune dysregulation, metabolic imbalance, and amplified pro-inflammatory cytokine signalling (TNF-alpha, IL-6, IL-1beta). Left unaddressed at the root-cause level, arthritis causes irreversible joint destruction, systemic inflammation, and profound decline in functional capacity and quality of life.

Key Symptoms

Chronic joint pain and tenderness
Morning stiffness (>30 min)
Joint swelling and warmth
Fatigue and poor sleep
Reduced range of motion
Systemic inflammation (elevated CRP)

Primary Causes

Immune dysregulation / autoimmunity
Gut dysbiosis & leaky gut
Chronic systemic inflammation
Metabolic syndrome & obesity
Hormonal deficiency (oestrogen, vitamin D)
Oxidative stress & toxic burden

Treatment Approach

Anti-inflammatory nutritional protocol
Omega-3, curcumin, boswellia therapy
Gut microbiome restoration
IV nutrient therapy
Hormonal optimisation
Acupuncture & detoxification

What Is Arthritis?

Arthritis is one of the most common yet most misunderstood chronic conditions — it is not a single disease, and it is not an inevitable consequence of aging.

In plain language, arthritis means that one or more of your joints are inflamed. A joint is the point where two bones meet — protected by cartilage, lubricated by synovial fluid, and stabilised by surrounding ligaments and tendons. When this complex architecture breaks down — whether through mechanical overload, immune attack, or metabolic dysfunction — the result is the pain, stiffness, and swelling that define arthritis. What distinguishes the more than 100 subtypes is the mechanism of that breakdown and which joints are affected.

The biological mechanisms differ by type, but they share a common upstream driver: chronic, unresolved inflammation. In osteoarthritis, chondrocytes (the cells that maintain cartilage) become overwhelmed by mechanical stress and metabolic toxins, releasing matrix metalloproteinases that degrade the cartilage matrix. In rheumatoid arthritis, the immune system generates auto-antibodies (anti-cyclic citrullinated peptide antibodies, or anti-CCP) that bind to joint tissue, triggering complement activation, neutrophil infiltration, and pannus formation — an aggressive inflammatory tissue that erodes bone and cartilage. In gout, monosodium urate crystals deposit in joints, triggering acute NLRP3 inflammasome activation and intense neutrophil-driven inflammation.

Functional medicine recognises arthritis as a systems-level condition — one whose root causes extend beyond the joint into the gut microbiome, liver detoxification pathways, hormonal milieu, nutritional status, and environmental toxic burden. This is why standard NSAIDs and DMARDs, while important in the acute setting, rarely produce lasting remission: they suppress the symptom without addressing the underlying drivers. At Patients Medical, we investigate and treat those drivers systematically.

Arthritis is extraordinarily common. Approximately 58.5 million US adults — one in four — carry an arthritis diagnosis, and projections suggest this will rise to 78 million by 2040 as the population ages and the obesity epidemic continues. Women bear a disproportionate burden: they account for nearly 60% of all arthritis cases and experience greater severity of disease, particularly with rheumatoid and fibromyalgia-related arthritis.

Articular Cartilage

The smooth, rubbery tissue covering the ends of bones within joints. Composed of type II collagen and proteoglycans, it absorbs compressive load and reduces friction. In osteoarthritis, cartilage matrix breakdown via MMP enzymes leads to surface fibrillation, thinning, and eventual full-thickness loss — exposing subchondral bone and causing the characteristic joint-space narrowing seen on X-ray.

Synovial Membrane

The thin tissue lining of the joint capsule that produces synovial fluid for lubrication and cartilage nutrition. In rheumatoid arthritis, immune complex deposition in the synovium triggers CD4+ T cell and B cell activation, causing synovial hyperplasia and pannus formation — a destructive inflammatory tissue that invades and erodes both cartilage and bone. Elevated IL-6 in the synovium also promotes osteoclast activation, accelerating bone erosion.

Subchondral Bone

The dense bone layer immediately beneath articular cartilage that provides structural support and participates in bidirectional signalling with chondrocytes. In both OA and RA, subchondral bone undergoes pathological remodelling: in OA, sclerosis and osteophyte formation occur; in RA, periarticular osteoporosis and erosions develop due to RANKL-mediated osteoclast activation. Restoring bone mineral density through vitamin D3, K2, and magnesium support is a key component of integrative arthritis care.

Signs & Symptoms of Arthritis

Arthritis produces a wide spectrum of symptoms because inflammation in joints does not stay contained — it generates systemic cytokine signalling that affects energy, sleep, cognitive function, and mood. Understanding the full symptom picture is essential for accurate diagnosis and treatment.

Joint & Pain Symptoms

Chronic joint pain

Driven by prostaglandin release, bradykinin sensitisation, and central pain amplification — pain is often both peripheral and neurologically upregulated.

Morning stiffness

In RA, stiffness lasting over 60 minutes reflects overnight accumulation of inflammatory mediators in the synovium; in OA, gel phenomenon resolves within 30 minutes as synovial fluid warms and redistributes.

Joint swelling and warmth

Caused by synovial membrane hyperplasia and increased vascularity (angiogenesis) in the inflamed joint, resulting in measurable effusion and elevated intra-articular temperature.

Crepitus (grinding/cracking)

Results from loss of smooth articular surface and irregular cartilage fragments; audible and palpable crepitation is a hallmark finding in moderate-to-advanced osteoarthritis.

Joint deformity

In advanced RA, pannus-mediated erosion of the metacarpophalangeal joints produces characteristic ulnar deviation and swan-neck deformity; in OA, Heberden's nodes and Bouchard's nodes form at DIP and PIP joints.

Cognitive & Mental Symptoms

Brain fog and poor concentration

Elevated IL-6 and TNF-alpha cross the blood-brain barrier and impair hippocampal neurogenesis and prefrontal cortex function, producing the cognitive dulling and forgetfulness that arthritis patients commonly report.

Depression and anxiety

Chronic pain activates the HPA axis, raising cortisol and reducing serotonin synthesis; simultaneously, pro-inflammatory cytokines induce IDO enzyme upregulation, shifting tryptophan metabolism toward neurotoxic kynurenic acid rather than serotonin.

Sleep disturbance

Nocturnal joint pain and elevated IL-1beta disrupt slow-wave sleep architecture, reducing growth hormone secretion and impairing the overnight tissue repair cycle — worsening joint inflammation the following day.

Memory difficulties

Chronic systemic inflammation and cortisol elevation are associated with accelerated hippocampal volume loss and reduced BDNF (brain-derived neurotrophic factor), impairing memory consolidation and recall.

Mood irritability

Pain chronicity, sleep deprivation, and elevated inflammatory load directly impair prefrontal cortex regulation of the amygdala, lowering the threshold for irritability and emotional reactivity.

Energy & Systemic Symptoms

Profound fatigue

TNF-alpha and IL-6 act directly on the hypothalamus to reduce appetite and energy drive; mitochondrial dysfunction from oxidative stress further limits ATP production in both muscle and immune cells.

Low-grade fever (in RA)

Elevated IL-1beta and prostaglandin E2 act on the hypothalamic thermostat (POAH region), raising the temperature set-point and producing the mild but persistent fever characteristic of active RA flares.

Weight changes

Cachexia from TNF-alpha-driven muscle breakdown occurs in active RA; paradoxically, metabolic inflammation drives insulin resistance and visceral fat accumulation in OA and psoriatic arthritis, contributing to obesity-related joint loading.

Anaemia of chronic disease

IL-6 upregulates hepatic hepcidin production, blocking intestinal iron absorption and iron release from macrophages — producing a normocytic, normochromic anaemia that exacerbates fatigue in RA and other inflammatory arthritis types.

Lymph node swelling

Activated immune complexes in RA drain to regional lymph nodes, causing reactive lymphadenopathy near affected joints — a sign of active systemic immune engagement beyond the joint alone.

Metabolic & Extra-Articular Symptoms

Skin manifestations

In psoriatic arthritis, plaques result from IL-17-driven keratinocyte hyperproliferation; in RA, rheumatoid nodules (firm subcutaneous deposits of macrophages and fibroblasts) form at pressure points like elbows and knuckles.

Eye inflammation (uveitis)

Occurs in up to 40% of patients with ankylosing spondylitis and in juvenile idiopathic arthritis; HLA-B27-mediated immune activation in anterior chamber tissue causes painful, red-eye episodes requiring urgent ophthalmologic evaluation.

Digestive dysfunction

Intestinal permeability and microbiome dysbiosis are both a cause and a consequence of inflammatory arthritis; many patients experience bloating, irregular bowel habits, and food sensitivities that worsen joint symptoms when unaddressed.

Cardiovascular risk

Chronic elevation of CRP, fibrinogen, and homocysteine in inflammatory arthritis accelerates atherosclerosis; RA patients carry a 50–70% higher risk of cardiovascular events than age-matched controls — making metabolic monitoring essential.

Dry eyes and mouth (Sjögren's overlap)

Secondary Sjögren's syndrome occurs in 15–30% of RA patients; anti-Ro/SSA and anti-La/SSB antibodies attack exocrine glands, reducing lacrimal and salivary output and causing mucous membrane dryness.

The Four Major Types of Arthritis: What Distinguishes Each

Understanding which type of arthritis is driving your symptoms is the essential first step toward effective treatment — because the mechanisms, tests, and therapies differ substantially between types. A correct diagnosis prevents years of misdirected treatment.

01 Osteoarthritis (OA)

Cartilage degradation marker: CTX-II elevated

Osteoarthritis is the most prevalent form, affecting 32.5 million US adults. It results from a breakdown in the balance between cartilage matrix synthesis and degradation — driven by mechanical overload, chondrocyte senescence, and low-grade metabolic inflammation (termed “meta-inflammation”). OA preferentially affects weight-bearing joints: knees, hips, lumbar spine, and the distal and proximal interphalangeal joints of the hands. Unlike the older “wear and tear” narrative, modern research firmly establishes OA as an active inflammatory process involving synovitis, subchondral bone remodelling, and meniscal degeneration. Functional medicine targets adipokine excess, mitochondrial dysfunction in chondrocytes, and oxidative stress as modifiable upstream drivers.

02 Rheumatoid Arthritis (RA)

Anti-CCP antibodies: hallmark diagnostic marker

Rheumatoid arthritis is a systemic autoimmune disease in which molecular mimicry, HLA-DR allele susceptibility, and gut microbiome dysbiosis (particularly Prevotella copri overgrowth) trigger T cell and B cell activation against citrullinated proteins in joint tissue. RA causes symmetrical joint inflammation predominantly affecting the small joints of the hands, wrists, and feet, along with systemic manifestations including fatigue, anaemia, and elevated cardiovascular risk. Anti-CCP antibodies may be detectable up to 10 years before clinical symptoms. Functional medicine focuses on immunomodulation through gut repair, omega-3 and curcumin therapy, and stress reduction to reduce autoimmune driver burden alongside conventional DMARDs when appropriate.

03 Gout

Serum uric acid: typically >6.8 mg/d

Gout is a form of crystal arthropathy caused by the deposition of monosodium urate (MSU) crystals in joints and periarticular tissues, resulting from sustained hyperuricaemia. Acute gout attacks are among the most intensely painful medical experiences — caused by neutrophil-driven NLRP3 inflammasome activation in response to MSU crystals, producing explosive IL-1beta release. The first metatarsophalangeal joint (big toe) is the classic target (podagra), though the ankle, knee, and wrist are also common sites. Chronic tophaceous gout results in destructive joint damage. Functionally, hyperuricaemia is driven by fructose excess, alcohol, purine-rich diets, gut dysbiosis impairing uric acid clearance, and kidney insufficiency — all addressable through targeted interventions.

04 Psoriatic & Inflammatory Arthritis

IL-17 pathway activation: PsA; HLA-B27: AS

Psoriatic arthritis (PsA) affects 20–30% of people with psoriasis and can precede skin manifestations. It is driven by IL-17 and IL-23 pathway dysregulation and often presents with dactylitis (“sausage digits”), enthesitis (inflammation at tendon insertion sites), asymmetric oligoarthritis, and nail changes. Ankylosing spondylitis (AS) is an HLA-B27-associated spondyloarthropathy causing progressive inflammatory fusion of sacroiliac joints and vertebral bodies, leading to kyphosis and rigid “bamboo spine” deformity in advanced cases. Reactive arthritis follows GI or genitourinary infections and is typically self-limiting. All inflammatory arthritis subtypes respond to gut microbiome optimisation and IL-17/TNF-pathway modulation, making functional medicine an important complement to biologic therapy.

Causes & Risk Factors for Arthritis

Arthritis rarely has a single cause. In virtually every case, multiple interacting biological, environmental, and lifestyle factors converge to create a joint environment prone to inflammation and structural breakdown. Identifying your specific combination of drivers is the foundation of effective functional medicine treatment.

01

Gut Dysbiosis & Intestinal Permeability

Imbalanced gut microbiome (reduced Faecalibacterium prausnitzii, elevated Prevotella copri) and leaky gut allow LPS endotoxin and microbial antigens to enter systemic circulation, chronically activating TLR4 receptors and producing TNF-alpha, IL-6, and IL-17 — directly fuelling joint inflammation.

02

Chronic Systemic Inflammation

Persistent elevation of NF-kB — the master inflammatory transcription factor — from dietary, toxic, microbial, or psychosocial stressors sustains continuous cytokine production that both initiates and perpetuates arthritis in genetically susceptible individuals.

03

Autoimmune Dysregulation

In RA and PsA, loss of immune tolerance — mediated by epigenetic changes in regulatory T cells (Tregs), molecular mimicry with microbial peptides, and HLA-DR allele susceptibility — causes the immune system to generate auto-antibodies (anti-CCP, RF) and cytotoxic T cells that attack joint tissue.

04

Obesity & Metabolic Syndrome

Excess adipose tissue secretes pro-inflammatory adipokines (leptin, resistin, visfatin) that directly activate chondrocyte and synoviocyte inflammatory cascades; concurrently, mechanical overloading of cartilage accelerates OA progression — making the combination of inflammation and load particularly destructive.

05

Nutritional Deficiencies

Deficiencies in vitamin D3 (critical for Treg function and immune tolerance), magnesium (cofactor for 300+ enzymatic reactions including antioxidant defence), omega-3 fatty acids (precursors to anti-inflammatory resolvins and protectins), and collagen precursors (glycine, proline) impair joint tissue maintenance and immune regulation.

06

Hormonal Imbalances

Oestrogen deficiency after menopause dramatically increases RA risk and accelerates OA progression by reducing synovial lubrication and cartilage proteoglycan synthesis; low testosterone in men similarly impairs cartilage maintenance; thyroid dysfunction (particularly Hashimoto’s) drives systemic inflammation that worsens arthritis.

07

Oxidative Stress & Mitochondrial Dysfunction

Chondrocytes are particularly susceptible to reactive oxygen species (ROS) because cartilage is avascular and cannot rapidly replenish antioxidant defences; mitochondrial dysfunction reduces chondrocyte ATP production, impairing cartilage matrix repair and accelerating senescence.

08

Food Sensitivities & Dietary Triggers

IgG-mediated food sensitivities (to gluten, dairy, nightshades, and high-lectin foods) trigger delayed immune complex formation that deposits in joints and sustains low-grade synovial inflammation; fructose excess raises uric acid and feeds dysbiotic bacteria that produce LPS.

09

Heavy Metal & Toxic Burden

Cadmium, mercury, and lead accumulation inhibit antioxidant enzyme activity (superoxide dismutase, glutathione peroxidase), deplete intracellular glutathione, and activate NF-kB directly — all of which amplify joint inflammation and impair the cellular repair mechanisms that should protect cartilage.

10

Joint Injury & Biomechanical Stress

Previous ligament or meniscal injuries dramatically increase OA risk in affected joints (ACL injury raises knee OA risk by 50% within 15 years); chronic biomechanical malalignment (flat feet, leg length discrepancy, valgus/varus knee deformity) creates asymmetric loading that accelerates focal cartilage loss.

11

Genetic Susceptibility

HLA-DR4 and HLA-DR1 alleles are present in 70% of RA patients; HLA-B27 confers 200-fold increased risk for ankylosing spondylitis; COMT and MTHFR gene variants impair methyl group availability for inflammation resolution — but genes only determine susceptibility; environmental triggers determine expression.

12

Chronic Psychological Stress

HPA axis dysregulation from sustained psychosocial stress elevates cortisol, which initially suppresses inflammation but chronically promotes glucocorticoid receptor resistance, causing immune cells to become unresponsive to cortisol’s anti-inflammatory signalling — paradoxically worsening inflammatory arthritis over time.

Arthritis vs. Related Conditions: How to Tell the Difference

Several conditions overlap significantly with arthritis in their symptoms and even their laboratory findings. Accurate differentiation requires specific testing — and it is clinically critical, because the treatment approaches diverge substantially.

Feature	Osteoarthritis	Rheumatoid Arthritis	Fibromyalgia	Lupus (SLE)
Key biomarker	Elevated CTX-II (cartilage breakdown)	Anti-CCP, Rheumatoid Factor (RF)	Elevated Substance P; normal inflammatory markers	ANA, anti-dsDNA, low complement C3/C4
Best diagnostic test	X-ray (joint space narrowing); MRI for early OA	Anti-CCP antibody panel + synovial biopsy	Clinical (ACR criteria); exclusion of inflammatory disease	ANA panel + anti-dsDNA + urinalysis (renal involvement)
Hallmark symptom	Asymmetric joint pain worsened by activity	Symmetric small joint morning stiffness >1 hour	Widespread musculoskeletal pain + tenderness at 18 points	Malar rash + photosensitivity + polyarthritis
Systemic inflammation	Low-grade (elevated hs-CRP)	High (elevated CRP, ESR, ferritin)	Normal CRP and ESR	Variable — often elevated CRP, ESR, low WBC
Treatment approach	Cartilage support, weight loss, anti-inflammatory nutrition	DMARDs, biologics, immune modulation	CNS sensitisation therapies, gut repair, sleep optimisation	Immunosuppression + antimalarials + organ-specific monitoring
Functional medicine overlap	Gut repair, adipokine reduction, omega-3	Microbiome optimisation, anti-CCP reduction protocol	Adrenal support, mitochondrial support, GABA/magnesium	Anti-inflammatory diet, detox, stress management

Clinically important: Fibromyalgia and rheumatoid arthritis frequently co-exist — up to 20% of RA patients also meet fibromyalgia criteria. When fibromyalgia is misidentified as RA flare, patients may be unnecessarily escalated to stronger immunosuppression. Precise biomarker testing is essential to distinguish active synovitis from central sensitisation.

How We Diagnose Arthritis in NYC

Standard arthritis diagnosis often stops at X-rays and basic blood panels. At Patients Medical, we go further — identifying not just the type of arthritis but the specific biological drivers in your individual case, enabling targeted treatment rather than symptom suppression alone.

01 Comprehensive Autoimmune & Inflammatory Panel

We begin with a full autoimmune workup: Rheumatoid Factor (RF), anti-cyclic citrullinated peptide (anti-CCP) antibodies (95% specific for RA), antinuclear antibody (ANA) with reflex testing, anti-dsDNA, anti-Sm, anti-Ro/SSA, and anti-La/SSB. Inflammatory load is quantified via high-sensitivity CRP (hs-CRP), erythrocyte sedimentation rate (ESR), ferritin, and a full cytokine panel including IL-6, TNF-alpha, and IL-17. These markers tell us whether autoimmunity is present and how actively inflamed the system is — establishing a baseline against which we measure treatment response.

02 Gut Permeability & Microbiome Assessment

Given the central role of the gut-joint axis in inflammatory arthritis, we evaluate intestinal permeability using serum zonulin levels and lactulose/mannitol urine testing. Comprehensive stool microbiome analysis (via GI-MAP or Genova Diagnostics) identifies dysbiotic pathogens (including Prevotella copri), parasitic infections, small intestinal bacterial overgrowth (SIBO), and markers of intestinal inflammation (fecal calprotectin, secretory IgA). Food sensitivity IgG panel testing (ALCAT or Cyrex Array 3X for gluten reactivity) identifies delayed immune triggers maintaining joint inflammation.

03 Metabolic, Hormonal & Nutritional Status

A full metabolic panel includes fasting glucose, HbA1c (insulin resistance drives arthritis inflammation), uric acid (gout risk), lipid panel, and comprehensive metabolic panel. Hormonal evaluation includes oestradiol, testosterone (free and total), DHEA-S, morning cortisol, and full thyroid panel (TSH, Free T3, Free T4, anti-TPO, anti-thyroglobulin) — because Hashimoto’s thyroiditis co-occurs in 18% of RA patients. Nutritional assessment measures 25-hydroxy vitamin D3 (target 60–80 ng/mL), RBC magnesium (not serum), omega-3 index (EPA+DHA), zinc, and B12.

04 Oxidative Stress & Heavy Metal Testing

Oxidative stress biomarkers — including urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG, a DNA oxidation marker) and lipid peroxidation markers (F2-isoprostanes, malondialdehyde) — quantify the degree of free radical damage contributing to cartilage and synovial tissue injury. We also assess glutathione status (total and reduced) and mitochondrial function markers via organic acid testing. Heavy metal burden testing (serum and provoked urine challenge for mercury, lead, cadmium, and arsenic) is performed when toxic drivers are clinically suspected — particularly in patients with multi-system inflammation and poor response to standard treatment.

05 Imaging & Functional Movement Assessment

We coordinate with radiology partners for targeted joint imaging: plain radiographs for joint space narrowing and osteophyte assessment, MRI for early cartilage pathology and synovitis quantification, and ultrasound for real-time synovial vascularity and effusion evaluation. A functional movement assessment by our clinical team evaluates biomechanical contributors — gait abnormalities, muscle imbalances, and postural patterns that increase mechanical joint stress. Bone density (DEXA scan) is ordered when osteoporosis is suspected as a concurrent condition, particularly in postmenopausal women and men over 60.

Does This Sound Like You?

Check the symptoms that apply to your experience

Joints that are painful, swollen, or warm to the touch
Morning stiffness lasting 30 minutes or more
Fatigue that doesn't improve with rest
Pain that is worse after periods of inactivity
Grinding or cracking sounds in your joints
Reduced grip strength or difficulty opening jars
Digestive issues alongside joint symptoms
Pain that limits your work or daily activities
Multiple doctors but no clear root-cause answer

Arthritis Treatment at Patients Medical NYC

Our approach to arthritis treatment is built on a core principle: managing pain is not enough. Real recovery requires systematically identifying and removing the biological drivers of joint inflammation — then rebuilding the tissue and immune environment that supports lasting joint health. Every treatment plan is fully personalised based on your biomarker profile, symptom pattern, and health history.

Targeted Nutraceutical Therapy

Prescription-grade nutraceuticals at therapeutic doses address the specific inflammatory pathways identified in your testing. Omega-3 fatty acids (EPA/DHA at 3–4g/day) reduce TNF-alpha and IL-1beta with an efficacy comparable to low-dose NSAIDs in clinical trials. Curcumin phytosome inhibits NF-kB with superior bioavailability; boswellia serrata (standardised AKBA) blocks 5-lipoxygenase to reduce leukotriene B4. Type II collagen, MSM, and hyaluronic acid support cartilage matrix. Vitamin D3 and K2 restore immune tolerance and bone density.

Omega-3 EPA/DHA

Curcumin Phytosome

Boswellia AKBA

Type II Collagen

Vitamin D3/K2

IV Nutrient Therapy for Arthritis

Intravenous nutrient infusions bypass gut absorption limitations to deliver high-dose anti-inflammatory and antioxidant agents directly into circulation. Our arthritis IV protocols typically include high-dose vitamin C (as an anti-inflammatory and collagen cofactor), glutathione (the master cellular antioxidant), B-complex vitamins for methylation support, and magnesium for muscle and joint relaxation. IV therapy produces faster clinical responses than oral supplementation and is particularly valuable during acute arthritis flares and for patients with significant gut malabsorption.

High-Dose Vitamin C

IV Glutathione

Magnesium Infusion

B-Complex IV

Gut Microbiome Restoration

Since the gut-joint axis is a primary driver of inflammatory arthritis, repairing intestinal barrier function and rebalancing the microbiome is a non-negotiable pillar of our treatment protocol. We use targeted 4R protocols (Remove, Replace, Reinoculate, Repair) personalised to your stool microbiome results. This includes antimicrobial/antifungal therapy for dysbiotic pathogens, precision probiotic repletion (L. rhamnosus GG, Akkermansia muciniphila), prebiotic fibre optimisation, and intestinal barrier repair agents (L-glutamine 10–15g/day, zinc carnosine, deglycyrrhizinated licorice). Food sensitivity elimination removes immune triggers maintaining joint inflammation.

4R Gut Protocol

L-Glutamine

Akkermansia support

Zinc Carnosine

Hormone Optimisation

Hormonal deficiencies are major but overlooked drivers of arthritis progression. When testing confirms oestrogen deficiency (postmenopausal or perimenopausal women), we discuss bioidentical hormone replacement therapy (BHRT) using oestradiol and progesterone, which maintains synovial lubrication and reduces systemic inflammatory burden. Low testosterone in men is addressed with bioidentical testosterone optimisation when indicated. Thyroid hormone optimisation (addressing Hashimoto’s and subclinical hypothyroidism) is essential in RA overlap cases. DHEA supplementation supports immune tolerance and anti-inflammatory corticosteroid production via adrenal pathways.

Bioidentical Oestradiol

DHEA

Testosterone Optimisation

Thyroid Support

Acupuncture & Craniosacral Therapy

Medical acupuncture stimulates peripheral sensory fibres that modulate spinal gate control mechanisms, reducing chronic arthritic pain without pharmacological side effects; meta-analyses confirm significant benefit for knee OA and RA over sham controls. Acupuncture also reduces serum CRP and IL-1beta in inflammatory arthritis. Craniosacral therapy addresses the fascia and dural tension patterns that restrict joint mobility and perpetuate the neurological pain amplification cycle. Both modalities are integrated into our treatment plans where appropriate and are performed by experienced licensed practitioners at our NYC clinic.

Medical Acupuncture

Craniosacral Therapy

Fascial Release

Detoxification & Heavy Metal Clearance

When heavy metal testing identifies significant burden, we implement a carefully supervised detoxification programme using chelation agents (DMSA or EDTA), high-dose glutathione IV, and binder therapy (activated charcoal, modified citrus pectin, chlorella) to safely bind and eliminate toxic metals. Simultaneously, we support all four phases of liver detoxification (Phase I CYP450 enzymes via indole-3-carbinol and B vitamins; Phase II conjugation via N-acetylcysteine, glycine, and sulforaphane) to prevent retoxification. Sauna therapy (infrared) is recommended where appropriate for additional skin-route elimination.

DMSA Chelation

IV Glutathione

NAC

Sulforaphane

Modified Citrus Pectin

What to Expect: Timeline & Monitoring

Weeks 1–4	Initial symptom relief as anti-inflammatory nutrition, omega-3, and curcumin begin modulating prostaglandin and NF-kB pathways. Pain scores typically improve 20–30%. IV nutrient therapy initiated if appropriate.
Weeks 4–12	Measurable reductions in hs-CRP and ESR. Morning stiffness duration shortens. Energy improves as gut repair reduces LPS load. Food sensitivities identified and eliminated. Hormone optimisation initiated where indicated.
Months 3–6	Anti-CCP and RF titres begin declining in RA patients with sustained treatment. Significant functional improvement in joint mobility and pain-free movement. Repeat gut microbiome testing confirms microbiome rebalancing.
Months 6–18	Long-term structural benefits: improved bone density on DEXA, preserved joint space on imaging, reduced need for rescue NSAIDs. Maintenance protocol established with quarterly biomarker monitoring to sustain remission.

Lifestyle Practices for Arthritis Recovery

Lifestyle interventions are not adjunctive to arthritis treatment — they are mechanistically active therapies that modulate gene expression, inflammatory signalling, and joint tissue repair. These specific, evidence-based practices can meaningfully alter the trajectory of your condition.

Aquatic & Low-Impact Exercise: 150 Minutes Per Week

Hydrotherapy and swimming allow full-range joint movement with dramatically reduced compressive load on articular cartilage — making them the gold-standard exercise modality for arthritis. Water buoyancy reduces effective body weight by 90%, enabling movement that would be painful on land. Target 30 minutes of pool-based exercise 5 days per week, or cycling (stationary or road) as an equivalent low-impact option. This frequency is supported by meta-analyses showing 40% pain reduction and 20% improvement in functional capacity in OA patients. Resistance training twice weekly preserves muscle mass, reduces joint load through improved muscular support, and counteracts the sarcopenia-driven weight gain that worsens arthritis.

Daily Parasympathetic Activation: 4-7-8 Breathing & HRV Training

Chronic pain maintains the nervous system in a persistent sympathetic (fight-or-flight) state that elevates cortisol, suppresses regulatory T cells, and amplifies central pain sensitivity. Counteracting this requires daily parasympathetic activation: practice 4-7-8 breathing (inhale 4 counts, hold 7 counts, exhale 8 counts) for 10 minutes morning and evening. This pattern stimulates the vagus nerve, reduces IL-6 secretion via the cholinergic anti-inflammatory pathway, and lowers HPA axis reactivity. Heart rate variability (HRV) biofeedback training (via devices like Garmin or Polar H10) provides measurable feedback on autonomic balance and has demonstrated significant reductions in RA disease activity scores in clinical trials.

Sleep Architecture Optimisation: Target 7.5–9 Hours with Sleep Staging

Deep slow-wave sleep (SWS) is the primary window for growth hormone secretion, cartilage proteoglycan synthesis, and inflammatory resolution — making sleep quantity and quality a direct therapeutic target in arthritis. Maintain a fixed sleep and wake time (within 30 minutes, 7 days per week) to stabilise circadian cortisol patterns. Eliminate blue light exposure 90 minutes before bed to support melatonin onset. Melatonin has direct anti-inflammatory effects on joint tissue by scavenging reactive oxygen species and inhibiting NF-kB. Magnesium glycinate (400–600mg at bedtime) reduces nocturnal muscle pain and supports deep sleep architecture. If sleep apnoea is suspected, polysomnography should be arranged — untreated OSA dramatically worsens inflammatory arthritis through chronic nocturnal hypoxia.

Contrast Hydrotherapy & Infrared Sauna: 3–4 Sessions Per Week

Infrared sauna (30–45 minutes at 55–65°C) produces beneficial mild hyperthermia that increases local circulation to joint capsules, mobilises stored toxins for elimination via sweat, and has been shown in two randomised trials to reduce pain and stiffness in RA patients. The heat-shock protein (HSP70) response triggered by sauna exposure modulates immune activity and promotes cellular repair in stressed joint tissues. Contrast hydrotherapy (alternating 3 minutes of warm water with 30 seconds of cold water, repeated 3–5 cycles) enhances lymphatic drainage from inflamed joints and reduces morning oedema. Always consult your physician before starting sauna therapy if cardiovascular disease is present.

Yoga & Tai Chi: 3 Sessions Per Week Minimum

Multiple RCTs demonstrate that yoga and tai chi specifically outperform conventional stretching for arthritis outcomes, improving joint flexibility, balance, and disease activity scores. The combination of controlled movement, breath-work, and proprioceptive challenge in these practices trains the small stabilising muscles around joints while engaging the parasympathetic nervous system. Tai chi is particularly well-studied for knee OA, with a 2016 NEJM study showing outcomes equivalent to physical therapy. Both practices also address the psychological dimension of chronic arthritis — reducing depression, catastrophising, and central sensitisation. Start with a teacher-guided programme; chair yoga is available for those with significant mobility limitations.

Daily Sun Exposure & Vitamin D Optimisation

Vitamin D3 deficiency — defined as serum 25-OH-D below 30 ng/mL — is present in over 60% of RA patients and is independently associated with higher disease activity scores and faster radiographic progression. Vitamin D3 exerts profound immunomodulatory effects: it promotes regulatory T cell (Treg) differentiation, suppresses Th17 cell activity (which drives IL-17 production in PsA and RA), and directly inhibits synovial fibroblast proliferation. Aim for 15–20 minutes of midday sun exposure on large skin surface areas (arms and legs) daily. Because sun alone is rarely sufficient to achieve therapeutic serum levels, we typically prescribe supplemental vitamin D3 (5,000–10,000 IU/day) with vitamin K2 (MK-7 form, 180–360 mcg/day), targeting serum 25-OH-D levels of 60–80 ng/mL. Serum levels must be monitored every 3–6 months to avoid toxicity.

Diet & Nutrition Guide for Arthritis

Diet is not a peripheral support for arthritis treatment — it is a primary therapy. Every meal either activates or inhibits the NF-kB pathway, regulates the gut microbiome composition that drives or dampens joint inflammation, and supplies or depletes the micronutrients required for cartilage matrix synthesis and immune regulation. The foods below are categorised by their mechanistic effects on arthritis pathways, not by general “healthy eating” principles.

Single Most Important Dietary Change

Eliminate all added sugar and refined fructose immediately. Dietary fructose is the most potent stimulus for uric acid production (activating xanthine oxidase) and simultaneously feeds dysbiotic gram-negative bacteria that produce LPS — the bacterial endotoxin that directly activates TLR4 and NF-kB in synovial tissue. Eliminating sugar is the single intervention most consistently associated with reduced joint pain across all arthritis subtypes.

Eat — Foods That Support Recovery

Wild-caught fatty fish: Salmon, mackerel, sardines: highest source of EPA and DHA, which generate anti-inflammatory resolvins and protectins that actively resolve synovial inflammation
Tart cherries: Anthocyanins inhibit COX-2 (the same enzyme targeted by NSAIDs) and reduce uric acid levels; 8 oz tart cherry juice daily has been shown to prevent gout attacks
Leafy greens (spinach, kale, arugula): High in vitamin K1 (essential for cartilage matrix protein activation), folate (supports methylation and inflammation resolution), and magnesium
Turmeric with black pepper: Curcumin inhibits NF-kB, COX-2, and LOX pathways; piperine in black pepper increases curcumin bioavailability by 2,000%
Bone broth: Rich in type II collagen, glycine, proline, and hydroxyproline — the structural precursors of articular cartilage matrix; also supports gut barrier integrity
Extra virgin olive oil: Oleocanthal inhibits COX-1 and COX-2 enzymes with potency similar to ibuprofen at amounts achievable through dietary intake; polyphenols reduce oxidative stress in chondrocytes
Fermented foods (kefir, kimchi, sauerkraut): Introduce diverse Lactobacillus and Bifidobacterium species that restore gut barrier integrity and downregulate TLR4-mediated immune activation
Colourful vegetables (peppers, beets, berries): Quercetin, resveratrol, and betalains in these foods inhibit NLRP3 inflammasome activation — the key driver of acute gout and flares in crystal arthropathy
Walnuts and flaxseeds: Provide ALA omega-3 precursors and ellagitannins (converted to urolithin A by gut bacteria) which inhibit mTOR-mediated inflammatory signalling in synovial cells

Avoid — Foods That Worsen Arthritis

Sugar and high-fructose corn syrup: Directly elevates uric acid via xanthine oxidase; feeds LPS-producing gram-negative bacteria; activates AGE production that cross-links and stiffens cartilage matrix
Seed and vegetable oils (soybean, corn, sunflower): Extremely high in omega-6 arachidonic acid, which is the direct precursor to pro-inflammatory prostaglandin E2 and leukotriene B4 that drive joint inflammation
Gluten (wheat, barley, rye): Activates zonulin and increases intestinal permeability in susceptible individuals; gluten peptides can act as molecular mimics for joint tissue antigens in RA and PsA
Conventional dairy: Casein A1 protein generates beta-casomorphin-7 peptides that trigger gut inflammation in sensitive individuals; dairy is among the most common IgG food sensitivities identified in arthritis patients
Nightshade vegetables (tomatoes, peppers, aubergine): Contain solanine alkaloids that may increase gut permeability and trigger joint inflammation in a subset of arthritis patients; clinical elimination trial is recommended
Processed and red meat: High purine content raises uric acid (gout risk); advanced glycation end-products (AGEs) in grilled/barbecued meat cross-link cartilage collagen and activate RAGE receptors, amplifying joint inflammation
Alcohol: Dramatically raises uric acid (blocks renal urate excretion) and increases gut permeability, worsening LPS translocation; beer (high in purines) is the most potent gout trigger
Ultra-processed foods: Emulsifiers (carrageenan, polysorbate-80) in processed foods disrupt the gut mucus layer and microbiome, promoting the LPS-driven systemic inflammation that feeds all arthritis subtypes

Related & Overlapping Conditions

Arthritis rarely exists in isolation. The shared upstream drivers — systemic inflammation, gut dysbiosis, hormonal imbalance, and immune dysregulation — mean that arthritis frequently coexists with or precedes these related conditions. Identifying and treating these overlaps is essential for comprehensive recovery.

Fibromyalgia

Approximately 15–30% of rheumatoid arthritis patients also meet diagnostic criteria for fibromyalgia. Both conditions share drivers of central sensitisation, sleep disruption, and HPA axis dysregulation, but fibromyalgia produces tenderness at characteristic pressure points without structural joint damage — making precise biomarker differentiation essential.

Leaky Gut Syndrome

Intestinal permeability is both a cause and consequence of inflammatory arthritis. Zonulin-mediated tight junction dysfunction allows LPS endotoxin and food antigens to fuel joint inflammation; repairing the gut barrier is one of the highest-yield interventions in the functional medicine treatment of arthritis.

Hashimoto's Thyroiditis

Hashimoto’s thyroiditis co-occurs in 18–25% of rheumatoid arthritis patients, reflecting shared HLA allele susceptibility and gut microbiome disruption. Untreated Hashimoto’s drives systemic inflammation that directly worsens joint disease; conversely, treating thyroid autoimmunity often produces meaningful improvement in arthritis symptoms.

Osteoporosis

Osteoporosis and arthritis share the risk factors of oestrogen deficiency, vitamin D insufficiency, and physical inactivity. In RA, chronic glucocorticoid use and RANKL-mediated osteoclast activation accelerate bone mineral density loss. DEXA scanning and bone health optimisation are integrated into our arthritis care protocols.

Metabolic Syndrome

Obesity, insulin resistance, hypertension, and dyslipidaemia collectively define metabolic syndrome — all four components produce adipokine excess and chronic NF-kB activation that directly drives arthritis progression. Addressing metabolic syndrome is not optional in arthritis care; it is mechanistically essential.

Chronic Fatigue

The profound fatigue associated with inflammatory arthritis — driven by IL-6, TNF-alpha, mitochondrial dysfunction, and anaemia of chronic disease — significantly overlaps with chronic fatigue syndrome. Distinguishing cytokine-mediated fatigue from primary CFS requires careful workup; both respond to mitochondrial support and gut repair protocols.

When to See a Doctor About Arthritis

If you have been managing joint pain with over-the-counter medications and lifestyle adjustments but have not received a comprehensive root-cause evaluation, you deserve better. Many patients with arthritis spend years — sometimes decades — symptom-managing without ever identifying the biological drivers that are sustaining their disease. These are the signals that tell us it is time for a thorough functional medicine workup.

Seek a Functional Medicine Evaluation If:

Joint pain or stiffness persisting more than 6 weeks
Joint symptoms accompanied by significant fatigue
Standard blood panels are "normal" but symptoms persist
Known RA but disease activity poorly controlled
Recent onset of joint pain after antibiotic use or infection

Morning stiffness lasting longer than 30 minutes
Multiple joints involved, especially symmetrically
OA progression despite weight loss and exercise
Joint pain accompanied by digestive symptoms (bloating, IBS)
Family history of RA, lupus, or psoriasis with new joint symptoms

🚨 Seek Emergency Medical Evaluation Immediately If:

Sudden, severe joint swelling with fever over 38.5°C (101.3°F)
that is hot, red, and exquisitely tender to light touch (possible septic arthritis)
Inability to bear weight or move a joint following injury
Chest pain or shortness of breath in a patient with known RA (pericarditis)
Sudden eye pain and vision change with RA (acute uveitis)
Rapidly worsening neurological symptoms with ankylosing spondylitis

What Our Patients Say About Arthritis Treatment

The following testimonials reflect the experiences of our patients. Individual results vary. Names have been changed to protect privacy.

After 11 years of rheumatoid arthritis managed with methotrexate, I was still having flares every 6–8 weeks. Dr. Gulati ran tests my rheumatologist had never ordered — a stool microbiome panel, food sensitivity testing, and a gut permeability assessment. Within three months of following the gut repair protocol and eliminating gluten and dairy, my CRP dropped from 18 to 2.4. I've had zero flares in eight months. I finally understand what was driving my disease.

I'm 58 and my knee osteoarthritis was so severe my orthopaedic surgeon had recommended replacement. I wanted to try every possible alternative first. The functional medicine programme here — IV therapy, omega-3 protocol, targeted nutraceuticals, and a complete dietary overhaul — got me from a pain level of 8/10 daily to a manageable 2/10 within five months. I've postponed surgery indefinitely and am back to hiking. I wish I had found this approach 10 years ago.

I was dismissed by three different doctors who told me my joint pain was "just stress" because my ANA was weakly positive but didn't meet lupus criteria. Dr. Gulati ordered a comprehensive cytokine panel and found dramatically elevated IL-17 — consistent with early psoriatic arthritis. The targeted treatment has been life-changing. More importantly, having a physician who actually listened and investigated thoroughly — rather than just telling me to take ibuprofen — gave me my confidence back.

Explore Our Blog For More Insights

Frequently Asked Questions About Arthritis

What is arthritis and how many types are there?

Arthritis is not a single disease but an umbrella term for more than 100 distinct conditions that cause joint pain, inflammation, and structural damage. The two most common forms are osteoarthritis (OA), which results from mechanical wear and cartilage breakdown, and rheumatoid arthritis (RA), an autoimmune condition where the immune system attacks the synovial lining of joints. Other significant types include psoriatic arthritis, gout, ankylosing spondylitis, and reactive arthritis.

Arthritis affects approximately 58.5 million adults in the United States — roughly 24% of the adult population — making it the leading cause of work disability in the country. Women are disproportionately affected, comprising nearly 60% of all arthritis cases. From a functional medicine perspective, all forms of arthritis share a common upstream driver: systemic inflammation amplified by diet, gut dysbiosis, toxic burden, hormonal shifts, and oxidative stress. Identifying and addressing these root causes is central to the integrative treatment approach at Patients Medical.

How long does arthritis treatment take to show results?

The timeline for improvement in arthritis depends on the type, severity, duration of the condition, and how comprehensively root causes are addressed. Most patients undergoing a functional medicine protocol at Patients Medical notice meaningful reductions in pain and morning stiffness within 6 to 12 weeks of beginning an anti-inflammatory nutritional programme and targeted nutraceutical therapy.

Inflammatory biomarkers such as hs-CRP and ESR typically begin declining within 4 to 8 weeks when dietary changes and omega-3 supplementation are implemented consistently. Structural benefits — improved joint space preservation and reduced synovial thickening — typically become measurable on imaging over 6 to 18 months of sustained treatment. Autoimmune forms like rheumatoid arthritis generally require longer treatment windows and careful monitoring of antibody titres (anti-CCP and RF). Patients who address all modifiable drivers simultaneously — including gut permeability, food sensitivities, hormonal imbalances, and toxic burden — tend to achieve the most durable outcomes.

What tests are used to diagnose arthritis?

Diagnosing arthritis accurately — and identifying its root causes — requires both conventional and functional medicine laboratory testing. Standard tests include Rheumatoid Factor (RF), anti-cyclic citrullinated peptide (anti-CCP) antibodies, high-sensitivity C-reactive protein (hs-CRP), erythrocyte sedimentation rate (ESR), a complete blood count (CBC), and a comprehensive metabolic panel including uric acid to evaluate for gout. Antinuclear antibody (ANA) testing is used when lupus-related arthritis is suspected.

Beyond these conventional markers, functional medicine physicians at Patients Medical use an expanded inflammatory cytokine panel (including IL-6, TNF-alpha, and IL-17), intestinal permeability markers (zonulin and lactulose/mannitol testing), food sensitivity IgG panels, oxidative stress biomarkers (8-OHdG), micronutrient assessments (vitamin D3, magnesium, omega-3 index), and heavy metal testing. These additional tests often reveal modifiable inflammatory drivers that standard rheumatology panels miss entirely, enabling a more targeted and effective treatment plan.

Can arthritis cause fatigue and weight gain?

Yes — fatigue and weight changes are well-documented systemic effects of arthritis, particularly in inflammatory and autoimmune forms. In rheumatoid arthritis, the same pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1beta) that attack joint tissue also act on the hypothalamus, disrupting energy regulation and sleep architecture, which produces profound fatigue. Chronic inflammation elevates cortisol output and promotes insulin resistance, both of which drive fat accumulation — particularly visceral adipose tissue — even when caloric intake has not changed.

Excess adipose tissue itself secretes adipokines such as leptin and resistin, which sustain the inflammatory cycle and worsen joint disease. Additionally, reduced mobility from joint pain leads to muscle atrophy and a lower metabolic rate, making weight management more difficult. Addressing these interconnected metabolic and inflammatory drivers — through anti-inflammatory nutrition, exercise adaptation, and hormonal optimisation — is a core focus of arthritis treatment at Patients Medical.

What is the difference between osteoarthritis and rheumatoid arthritis?

Osteoarthritis (OA) and rheumatoid arthritis (RA) are fundamentally different conditions that both cause joint damage but through distinct mechanisms. OA is primarily a degenerative disease driven by mechanical wear, cartilage matrix breakdown via matrix metalloproteinases, and low-grade metabolic inflammation — it typically affects weight-bearing joints asymmetrically (knees, hips, lumbar spine) and is strongly associated with age, obesity, and prior joint injury.

RA is an autoimmune disease where auto-antibodies (specifically anti-CCP and RF) trigger immune complex deposition in the synovial membrane, causing pannus formation and erosive joint destruction. RA affects joints symmetrically, predominantly the small joints of the hands and feet, and produces systemic symptoms including fever, fatigue, and extra-articular manifestations like rheumatoid nodules and interstitial lung disease. Morning stiffness in RA typically lasts more than one hour and improves with movement; OA stiffness generally resolves within 30 minutes. Laboratory diagnosis is key: anti-CCP antibodies are highly specific for RA (95% specificity), while OA diagnosis is primarily clinical and radiographic.

How does gut health affect arthritis?

The gut-joint axis is one of the most clinically significant and underappreciated drivers of both osteoarthritis and rheumatoid arthritis. Intestinal permeability (‘leaky gut’) allows lipopolysaccharides (LPS) from gram-negative bacteria and undigested food antigens to enter systemic circulation, triggering systemic immune activation and elevating inflammatory cytokines including TNF-alpha, IL-6, and IL-17 — all of which drive synovial inflammation.

Multiple studies have demonstrated that the gut microbiome composition differs significantly between individuals with RA and healthy controls: RA patients show reduced populations of Faecalibacterium prausnitzii (a major butyrate producer) and Bifidobacterium, and increased Prevotella copri, which generates immunogenic peptides that can cross-react with joint tissue through molecular mimicry. In patients with gout, gut dysbiosis impairs uric acid clearance, raising serum urate levels. Functional medicine testing for intestinal permeability, stool microbiome analysis, and food sensitivity panels allows Patients Medical physicians to identify and treat gut-level drivers of arthritis that conventional rheumatology panels do not address.

What supplements and natural treatments help arthritis?

Several nutraceuticals have strong clinical evidence supporting their use in arthritis management when used at therapeutic doses under physician guidance. Omega-3 fatty acids (EPA and DHA at 3–4 g/day) reduce TNF-alpha and IL-1beta production and have demonstrated clinical benefit comparable to low-dose NSAIDs in several RA trials. Curcumin (as phospholipid-bound or nanoparticle formulation for bioavailability) inhibits NF-kB, the master transcription factor of inflammation, with significant reductions in joint pain scores documented in both OA and RA studies. Boswellia serrata extract (standardised to AKBA) reduces leukotriene B4 synthesis and inhibits 5-lipoxygenase, making it particularly effective for inflammatory arthritis.

Collagen peptides (types I and II) support cartilage matrix synthesis; type II collagen at low doses also induces oral tolerance in RA. Vitamin D3 at targeted serum levels (60–80 ng/mL) modulates Th17/Treg balance, which is dysregulated in autoimmune arthritis. Magnesium glycinate reduces systemic inflammation and supports joint lubrication. Additional agents used at Patients Medical include methylsulfonylmethane (MSM), N-acetylcysteine (NAC), and IV glutathione for oxidative stress reduction. All supplementation should be supervised by a physician who can monitor blood levels and adjust doses based on your individual testing results.

Ready to understand your Arthritis?

At Patients Medical, we investigate every layer of your arthritis — from gut permeability and microbiome to inflammatory cytokines, hormonal status, and toxic burden — and build a personalised treatment protocol that targets your specific root causes, not just your symptoms.

Call us at (212) 794-8800 · 800 Second Avenue, Suite 900, New York, NY 10017

Begin Your Journey with Patients Medical

Patients Medical specializes in gently helping the patient identify the root cause of their medical issues and then assist them to recover from their problems to help them move forward to good health.

Request your consultation today!

To schedule an in person on Tele-medicine appointment, please call our office at (212) 794-8800 or email us at info@PatientsMedical.com We look forward to hearing from you

Our medical center in New York City.

Patients Medical PC
1148 Fifth Avenue, Suite 1B New York, NY 10128

Make an Appointment

TreatmentsTesting

Please leave this field empty.